A new program for adults with Medicare Part D will cut the price of Wegovy, Zepbound, and Foundayo. Here’s how to know if you qualify. A new Medicare GLP-1 Bridge program will offer select weight loss ...

Eli Lilly CEO Dave Ricks joins 'Varney & Co.' to discuss the Trump administration's new Medicare GLP-1 Bridge Program, which will offer eligible seniors access to Lilly weight loss medications for $50 ...

Medicare's new GLP-1 Bridge Program starts July 1 and runs through December 2027. Eligible Medicare Part D participants can get certain GLP-1 drugs for $50 a month at select pharmacies. The program ...

Beginning July 1, millions of people will be able to access GLP-1 weight-loss medications for the first time by paying a $50 monthly fee under a new Medicare pilot program. The Medicare GLP-1 Bridge ...

Share on Pinterest An estimated 14 million Medicare Part D recipients could obtain Wegovy, Foundayo, and Zepbound for $50 per month. Johner Images/Getty Images Federal officials announced the launch ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Millions of Medicare recipients could soon see the cost of popular ...

The new Medicare GLP-1 Bridge program, which will allow seniors to get certain GLP-1 drugs for just $50 a month and is part of The Better Approaches to Lifestyle and Nutrition for Comprehensive Health ...

Learning to program in C on an online platform can provide structured learning and a certification to show along with your resume. Learning C can still be useful in 2026, especially if you want to ...

Rust enters the top 10 for the first time, Python keeps the lead, C moves back above C++, and SQL edges out R in July’s rankings update. Rust has entered the TIOBE Index top 10 for the first time in ...

Invest in the best stocks under $50 with Interactive Brokers for fast trade execution. You don’t need thousands of dollars in the bank to get started investing. Just $50, or less, can help you buy ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...